An epidural catheter removal after recent percutaneous coronary intervention and coronary artery stenting: Epidural catheter and antiaggregation therapy
Serbian Journal of Anesthesia and Intensive Therapy · 2016
DOI: 10.5937/sjait1604083j ↗Kurz gefasst
Fachartikel in der Zeitschrift Serbian Journal of Anesthesia and Intensive Therapy, 2016. Verfasst von Nikola Joksic und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Anticoagulation and antiplatelet therapy in the presence of the epidural catheter is still controversial. It is well known that dual antiplatelet therapy is indicated for 12 months after the placement of drug-eluting stents (DES). Removal of an epidural catheter during that period is related to an increased risk of stent occlusion in case of discontinuation of platelet function inhibitors or, on the other hand, increased risk of epidural hematoma associated with neurological deficit if suppressed platelet function is still present. Case Report: Here we present a case of a 63-year-old man who was admitted to Institute for Cardiovascular Diseases Dedinje for elective aortic surgery. Before the induction, an epidural catheter was inserted at the Th10-Th11 epidural space. Uneventful surgery was performed under the combined epidural and general anesthesia. On the 2nd postoperative day, the patient sustained a ST depression myocardial infarction treated with percutaneous coronary intervention with DES placement, while epidural catheter was still in place. Dual antiplatelet therapy with 600mg of clopidogrel, 100 mg of acetilsalicylic acid (ASA) and low molecular weight heparin (LMWH) were started during the procedure. The next day, clopidogrel (75 mg) and ASA (100 mg) were continued as well as LMWH. The decision to remove the epidural catheter was made on the 9th postoperative day, after platelet aggregation assays were performed. Six hours after catheter removal the patient again received clopidogrel, ASA and LMWH. There were no signs of epidural hematoma.
Conclusion
This case shows that point-of-care testing with platelet aggregation assays may be useful in increasing the margin of safety for epidural catheter removal during dual antiplatelet therapy.
Zitieren
APA
Joksic, N., Jovic, M., Lesanovic, J., Babic, S., & Unic-Stojanovic, D. (2016). An epidural catheter removal after recent percutaneous coronary intervention and coronary artery stenting: Epidural catheter and antiaggregation therapy. Serbian Journal of Anesthesia and Intensive Therapy. https://doi.org/10.5937/sjait1604083j
Vancouver
Joksic N, Jovic M, Lesanovic J, Babic S, Unic-Stojanovic D. An epidural catheter removal after recent percutaneous coronary intervention and coronary artery stenting: Epidural catheter and antiaggregation therapy. Serbian Journal of Anesthesia and Intensive Therapy. 2016. doi:10.5937/sjait1604083j
BibTeX
@article{Joksic2016,
author = {Joksic, Nikola and Jovic, Miomir and Lesanovic, Jelena and Babic, Srdjan and Unic-Stojanovic, Dragana},
title = {An epidural catheter removal after recent percutaneous coronary intervention and coronary artery stenting: Epidural catheter and antiaggregation therapy},
journal = {Serbian Journal of Anesthesia and Intensive Therapy},
year = {2016},
doi = {10.5937/sjait1604083j}
}
EUVIMED